The U.S. Food and Drug Administration (USFDA) on Friday approved Merilog as biosimilar to Novolog (insulin aspart) for the ...

Researchers have proven that antibiotic-resistant strains of a harmful bacteria thrive in a diabetic infection environment.

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...

Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients ...

THOUSANDS of Irish people are diagnosed with type 2 diabetes every year. And one in ten globally are living with the chronic ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies, insulin administration is manually controlled, while hybrid ...

More than 36 million Americans have type 2 diabetes, a condition primarily attributed to the body's cells not responding to ...

Diabetes is a chronic disease that causes high blood sugar levels, and it is important that you know the signs of it. Niamh ...

Study results indicated that controlling diabetes with insulin helps to prevent the emergence of antibiotic-resistant S. aureus.

An innovative study, co-designed by Aboriginal Women, has led to remission of type 2 diabetes. The research described and ...

Antibiotics are powerful, fast-acting medications designed to eradicate bacterial infections. However, in recent years, their dependability has waned as antibiotic resistant bacteria continues to ...